SCI REP-UK 润色咨询

Scientific Reports

出版年份：2011 年文章数：160514 投稿命中率： 开通期刊会员，数据随心看

出版周期：Irregular 自引率：9.1% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2194666, encodeId=710421946668f, content=两个月还没找到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9fab6517805, createdName=ms7000000307422374, createdTime=Fri Mar 22 13:19:23 CST 2024, time=2024-03-22, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2198891, encodeId=7270219889143, content=请问一下大家在track snapp submission界面看是pass technical checks, 然后点view submission details看是under peer review，中间没有任何invite editor和invite reviewer的消息，请问这个是怎么回事呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa3d9260658, createdName=ms7000000714401863, createdTime=Wed Apr 17 04:05:25 CST 2024, time=昨天, status=1, ipAttribution=康涅狄格), GetPortalCommentsPageByObjectIdResponse(id=2199091, encodeId=18ae219909107, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0dd59219282, createdName=ms7000000828059346, createdTime=Thu Apr 18 10:52:12 CST 2024, time=1小时前, status=0, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2178836, encodeId=212721e883660, content=偏重的研究方向：生物信息学;肿瘤;Cancer<br>经验分享：- [ ] 2023.12.26 submission received - [ ] 2023.12.26 submission is under technical check - [ ] 2023.12.27 submission passed technical check - [ ] 2023.12.27 editor invited - [ ] 2023.12.27 editor assigned - [ ] 2023.12.27 reviewers invited(3) - [ ] 2023.12.27 1 reviewer(s) accepted - [ ] 2023.12.30 2 reviewer(s) accepted (Awaiting their report), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240102/21c3548d3cdf4d768708708330c1b141/805c04b8c592400eb28358eb81f1a145.jpg, createdBy=4a299119890, createdName=Dehors, createdTime=Tue Jan 02 18:33:59 CST 2024, time=2024-01-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2199014, encodeId=3c17219901402, content=偏重的研究方向：心血管<br>经验分享：记录sr投稿进程 2024/4/17 投稿并技术审查, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74fe5476004, createdName=ms4000001914246765, createdTime=Wed Apr 17 20:21:27 CST 2024, time=15小时前, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2173392, encodeId=267721e339254, content=想问下大佬们，到这个阶段之后，后续会有editer has been invited 或者多少多少reviewers has been invited吗？还是就过几个礼拜直接到decision了？ We will now find the most suitable editor to manage the next steps of your submission. If your submission is successful, they will invite reviewers to peer review your work. This process can take a few weeks., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230712/7b1f2dc9a324479e9877047bc3d85ecd/b95cd487c3e24b4d8bfa2fc6ab30880c.jpg, createdBy=aed48754576, createdName=发大文章带我一个二十作吧, createdTime=Wed Dec 06 23:30:26 CST 2023, time=2023-12-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2191565, encodeId=be7b2191565a6, content=The editors' decision can take several weeks as they may consult peer reviewers.今天我的从初始状态变成这个了，但是之前我看到都邀请审稿人了，这等于是又重新来了一遍啊，大佬们看看是这样吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ac75721162, createdName=峪奇不奇, createdTime=Wed Mar 06 18:58:02 CST 2024, time=2024-03-06, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2189221, encodeId=a79f21892213a, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：有没有已经接收的朋友，进入支付版面费的链接之后又让点一个按钮说发了另一个链接到邮件里，这是什么邮件啊，通讯作者没有收到邮件，有知道的朋友吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/04/30/d54ac6a658ea322ab205e4e0c0ff4977.jpg, createdBy=88b35325254, createdName=尽在不言中, createdTime=Sun Feb 25 09:09:20 CST 2024, time=2024-02-25, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2150320, encodeId=3ba1215032042, content=偏重的研究方向：生物信息学;肿瘤<br>经验分享：大家一般邀请几个审稿人啊，我邀请了五个，都接受审稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c178590765, createdName=ms5000000683483699, createdTime=Fri Jul 28 23:15:56 CST 2023, time=2023-07-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2195926, encodeId=31e8219592616, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向：基础<br>经验分享：2023年6月4日投稿，2024年3月25日接收。9个多月，终于过关了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a26a1720733, createdName=萝布, createdTime=Thu Mar 28 19:54:17 CST 2024, time=2024-03-28, status=1, ipAttribution=湖北省)]
    2024-03-22 ms7000000307422374 来自福建省

    两个月还没找到审稿人

    6

    展开6条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2194666, encodeId=710421946668f, content=两个月还没找到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9fab6517805, createdName=ms7000000307422374, createdTime=Fri Mar 22 13:19:23 CST 2024, time=2024-03-22, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2198891, encodeId=7270219889143, content=请问一下大家在track snapp submission界面看是pass technical checks, 然后点view submission details看是under peer review，中间没有任何invite editor和invite reviewer的消息，请问这个是怎么回事呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa3d9260658, createdName=ms7000000714401863, createdTime=Wed Apr 17 04:05:25 CST 2024, time=昨天, status=1, ipAttribution=康涅狄格), GetPortalCommentsPageByObjectIdResponse(id=2199091, encodeId=18ae219909107, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0dd59219282, createdName=ms7000000828059346, createdTime=Thu Apr 18 10:52:12 CST 2024, time=1小时前, status=0, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2178836, encodeId=212721e883660, content=偏重的研究方向：生物信息学;肿瘤;Cancer<br>经验分享：- [ ] 2023.12.26 submission received - [ ] 2023.12.26 submission is under technical check - [ ] 2023.12.27 submission passed technical check - [ ] 2023.12.27 editor invited - [ ] 2023.12.27 editor assigned - [ ] 2023.12.27 reviewers invited(3) - [ ] 2023.12.27 1 reviewer(s) accepted - [ ] 2023.12.30 2 reviewer(s) accepted (Awaiting their report), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240102/21c3548d3cdf4d768708708330c1b141/805c04b8c592400eb28358eb81f1a145.jpg, createdBy=4a299119890, createdName=Dehors, createdTime=Tue Jan 02 18:33:59 CST 2024, time=2024-01-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2199014, encodeId=3c17219901402, content=偏重的研究方向：心血管<br>经验分享：记录sr投稿进程 2024/4/17 投稿并技术审查, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74fe5476004, createdName=ms4000001914246765, createdTime=Wed Apr 17 20:21:27 CST 2024, time=15小时前, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2173392, encodeId=267721e339254, content=想问下大佬们，到这个阶段之后，后续会有editer has been invited 或者多少多少reviewers has been invited吗？还是就过几个礼拜直接到decision了？ We will now find the most suitable editor to manage the next steps of your submission. If your submission is successful, they will invite reviewers to peer review your work. This process can take a few weeks., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230712/7b1f2dc9a324479e9877047bc3d85ecd/b95cd487c3e24b4d8bfa2fc6ab30880c.jpg, createdBy=aed48754576, createdName=发大文章带我一个二十作吧, createdTime=Wed Dec 06 23:30:26 CST 2023, time=2023-12-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2191565, encodeId=be7b2191565a6, content=The editors' decision can take several weeks as they may consult peer reviewers.今天我的从初始状态变成这个了，但是之前我看到都邀请审稿人了，这等于是又重新来了一遍啊，大佬们看看是这样吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ac75721162, createdName=峪奇不奇, createdTime=Wed Mar 06 18:58:02 CST 2024, time=2024-03-06, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2189221, encodeId=a79f21892213a, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：有没有已经接收的朋友，进入支付版面费的链接之后又让点一个按钮说发了另一个链接到邮件里，这是什么邮件啊，通讯作者没有收到邮件，有知道的朋友吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/04/30/d54ac6a658ea322ab205e4e0c0ff4977.jpg, createdBy=88b35325254, createdName=尽在不言中, createdTime=Sun Feb 25 09:09:20 CST 2024, time=2024-02-25, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2150320, encodeId=3ba1215032042, content=偏重的研究方向：生物信息学;肿瘤<br>经验分享：大家一般邀请几个审稿人啊，我邀请了五个，都接受审稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c178590765, createdName=ms5000000683483699, createdTime=Fri Jul 28 23:15:56 CST 2023, time=2023-07-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2195926, encodeId=31e8219592616, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向：基础<br>经验分享：2023年6月4日投稿，2024年3月25日接收。9个多月，终于过关了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a26a1720733, createdName=萝布, createdTime=Thu Mar 28 19:54:17 CST 2024, time=2024-03-28, status=1, ipAttribution=湖北省)]
    昨天 ms7000000714401863 来自康涅狄格

    请问一下大家在track snapp submission界面看是pass technical checks, 然后点view submission details看是under peer review，中间没有任何invite editor和invite reviewer的消息，请问这个是怎么回事呀？

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2194666, encodeId=710421946668f, content=两个月还没找到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9fab6517805, createdName=ms7000000307422374, createdTime=Fri Mar 22 13:19:23 CST 2024, time=2024-03-22, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2198891, encodeId=7270219889143, content=请问一下大家在track snapp submission界面看是pass technical checks, 然后点view submission details看是under peer review，中间没有任何invite editor和invite reviewer的消息，请问这个是怎么回事呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa3d9260658, createdName=ms7000000714401863, createdTime=Wed Apr 17 04:05:25 CST 2024, time=昨天, status=1, ipAttribution=康涅狄格), GetPortalCommentsPageByObjectIdResponse(id=2199091, encodeId=18ae219909107, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0dd59219282, createdName=ms7000000828059346, createdTime=Thu Apr 18 10:52:12 CST 2024, time=1小时前, status=0, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2178836, encodeId=212721e883660, content=偏重的研究方向：生物信息学;肿瘤;Cancer<br>经验分享：- [ ] 2023.12.26 submission received - [ ] 2023.12.26 submission is under technical check - [ ] 2023.12.27 submission passed technical check - [ ] 2023.12.27 editor invited - [ ] 2023.12.27 editor assigned - [ ] 2023.12.27 reviewers invited(3) - [ ] 2023.12.27 1 reviewer(s) accepted - [ ] 2023.12.30 2 reviewer(s) accepted (Awaiting their report), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240102/21c3548d3cdf4d768708708330c1b141/805c04b8c592400eb28358eb81f1a145.jpg, createdBy=4a299119890, createdName=Dehors, createdTime=Tue Jan 02 18:33:59 CST 2024, time=2024-01-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2199014, encodeId=3c17219901402, content=偏重的研究方向：心血管<br>经验分享：记录sr投稿进程 2024/4/17 投稿并技术审查, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74fe5476004, createdName=ms4000001914246765, createdTime=Wed Apr 17 20:21:27 CST 2024, time=15小时前, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2173392, encodeId=267721e339254, content=想问下大佬们，到这个阶段之后，后续会有editer has been invited 或者多少多少reviewers has been invited吗？还是就过几个礼拜直接到decision了？ We will now find the most suitable editor to manage the next steps of your submission. If your submission is successful, they will invite reviewers to peer review your work. This process can take a few weeks., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230712/7b1f2dc9a324479e9877047bc3d85ecd/b95cd487c3e24b4d8bfa2fc6ab30880c.jpg, createdBy=aed48754576, createdName=发大文章带我一个二十作吧, createdTime=Wed Dec 06 23:30:26 CST 2023, time=2023-12-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2191565, encodeId=be7b2191565a6, content=The editors' decision can take several weeks as they may consult peer reviewers.今天我的从初始状态变成这个了，但是之前我看到都邀请审稿人了，这等于是又重新来了一遍啊，大佬们看看是这样吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ac75721162, createdName=峪奇不奇, createdTime=Wed Mar 06 18:58:02 CST 2024, time=2024-03-06, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2189221, encodeId=a79f21892213a, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：有没有已经接收的朋友，进入支付版面费的链接之后又让点一个按钮说发了另一个链接到邮件里，这是什么邮件啊，通讯作者没有收到邮件，有知道的朋友吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/04/30/d54ac6a658ea322ab205e4e0c0ff4977.jpg, createdBy=88b35325254, createdName=尽在不言中, createdTime=Sun Feb 25 09:09:20 CST 2024, time=2024-02-25, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2150320, encodeId=3ba1215032042, content=偏重的研究方向：生物信息学;肿瘤<br>经验分享：大家一般邀请几个审稿人啊，我邀请了五个，都接受审稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c178590765, createdName=ms5000000683483699, createdTime=Fri Jul 28 23:15:56 CST 2023, time=2023-07-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2195926, encodeId=31e8219592616, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向：基础<br>经验分享：2023年6月4日投稿，2024年3月25日接收。9个多月，终于过关了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a26a1720733, createdName=萝布, createdTime=Thu Mar 28 19:54:17 CST 2024, time=2024-03-28, status=1, ipAttribution=湖北省)]
    1小时前 ms7000000828059346 来自贵州省


    前往app查看评论内容

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2194666, encodeId=710421946668f, content=两个月还没找到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9fab6517805, createdName=ms7000000307422374, createdTime=Fri Mar 22 13:19:23 CST 2024, time=2024-03-22, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2198891, encodeId=7270219889143, content=请问一下大家在track snapp submission界面看是pass technical checks, 然后点view submission details看是under peer review，中间没有任何invite editor和invite reviewer的消息，请问这个是怎么回事呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa3d9260658, createdName=ms7000000714401863, createdTime=Wed Apr 17 04:05:25 CST 2024, time=昨天, status=1, ipAttribution=康涅狄格), GetPortalCommentsPageByObjectIdResponse(id=2199091, encodeId=18ae219909107, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0dd59219282, createdName=ms7000000828059346, createdTime=Thu Apr 18 10:52:12 CST 2024, time=1小时前, status=0, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2178836, encodeId=212721e883660, content=偏重的研究方向：生物信息学;肿瘤;Cancer<br>经验分享：- [ ] 2023.12.26 submission received - [ ] 2023.12.26 submission is under technical check - [ ] 2023.12.27 submission passed technical check - [ ] 2023.12.27 editor invited - [ ] 2023.12.27 editor assigned - [ ] 2023.12.27 reviewers invited(3) - [ ] 2023.12.27 1 reviewer(s) accepted - [ ] 2023.12.30 2 reviewer(s) accepted (Awaiting their report), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240102/21c3548d3cdf4d768708708330c1b141/805c04b8c592400eb28358eb81f1a145.jpg, createdBy=4a299119890, createdName=Dehors, createdTime=Tue Jan 02 18:33:59 CST 2024, time=2024-01-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2199014, encodeId=3c17219901402, content=偏重的研究方向：心血管<br>经验分享：记录sr投稿进程 2024/4/17 投稿并技术审查, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74fe5476004, createdName=ms4000001914246765, createdTime=Wed Apr 17 20:21:27 CST 2024, time=15小时前, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2173392, encodeId=267721e339254, content=想问下大佬们，到这个阶段之后，后续会有editer has been invited 或者多少多少reviewers has been invited吗？还是就过几个礼拜直接到decision了？ We will now find the most suitable editor to manage the next steps of your submission. If your submission is successful, they will invite reviewers to peer review your work. This process can take a few weeks., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230712/7b1f2dc9a324479e9877047bc3d85ecd/b95cd487c3e24b4d8bfa2fc6ab30880c.jpg, createdBy=aed48754576, createdName=发大文章带我一个二十作吧, createdTime=Wed Dec 06 23:30:26 CST 2023, time=2023-12-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2191565, encodeId=be7b2191565a6, content=The editors' decision can take several weeks as they may consult peer reviewers.今天我的从初始状态变成这个了，但是之前我看到都邀请审稿人了，这等于是又重新来了一遍啊，大佬们看看是这样吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ac75721162, createdName=峪奇不奇, createdTime=Wed Mar 06 18:58:02 CST 2024, time=2024-03-06, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2189221, encodeId=a79f21892213a, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：有没有已经接收的朋友，进入支付版面费的链接之后又让点一个按钮说发了另一个链接到邮件里，这是什么邮件啊，通讯作者没有收到邮件，有知道的朋友吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/04/30/d54ac6a658ea322ab205e4e0c0ff4977.jpg, createdBy=88b35325254, createdName=尽在不言中, createdTime=Sun Feb 25 09:09:20 CST 2024, time=2024-02-25, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2150320, encodeId=3ba1215032042, content=偏重的研究方向：生物信息学;肿瘤<br>经验分享：大家一般邀请几个审稿人啊，我邀请了五个，都接受审稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c178590765, createdName=ms5000000683483699, createdTime=Fri Jul 28 23:15:56 CST 2023, time=2023-07-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2195926, encodeId=31e8219592616, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向：基础<br>经验分享：2023年6月4日投稿，2024年3月25日接收。9个多月，终于过关了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a26a1720733, createdName=萝布, createdTime=Thu Mar 28 19:54:17 CST 2024, time=2024-03-28, status=1, ipAttribution=湖北省)]
    2024-01-02 Dehors 来自江苏省

    偏重的研究方向：生物信息学;肿瘤;Cancer
    经验分享：- [ ] 2023.12.26 submission received - [ ] 2023.12.26 submission is under technical check - [ ] 2023.12.27 submission passed technical check - [ ] 2023.12.27 editor invited - [ ] 2023.12.27 editor assigned - [ ] 2023.12.27 reviewers invited(3) - [ ] 2023.12.27 1 reviewer(s) accepted - [ ] 2023.12.30 2 reviewer(s) accepted (Awaiting their report)

    12

    展开12条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2194666, encodeId=710421946668f, content=两个月还没找到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9fab6517805, createdName=ms7000000307422374, createdTime=Fri Mar 22 13:19:23 CST 2024, time=2024-03-22, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2198891, encodeId=7270219889143, content=请问一下大家在track snapp submission界面看是pass technical checks, 然后点view submission details看是under peer review，中间没有任何invite editor和invite reviewer的消息，请问这个是怎么回事呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa3d9260658, createdName=ms7000000714401863, createdTime=Wed Apr 17 04:05:25 CST 2024, time=昨天, status=1, ipAttribution=康涅狄格), GetPortalCommentsPageByObjectIdResponse(id=2199091, encodeId=18ae219909107, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0dd59219282, createdName=ms7000000828059346, createdTime=Thu Apr 18 10:52:12 CST 2024, time=1小时前, status=0, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2178836, encodeId=212721e883660, content=偏重的研究方向：生物信息学;肿瘤;Cancer<br>经验分享：- [ ] 2023.12.26 submission received - [ ] 2023.12.26 submission is under technical check - [ ] 2023.12.27 submission passed technical check - [ ] 2023.12.27 editor invited - [ ] 2023.12.27 editor assigned - [ ] 2023.12.27 reviewers invited(3) - [ ] 2023.12.27 1 reviewer(s) accepted - [ ] 2023.12.30 2 reviewer(s) accepted (Awaiting their report), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240102/21c3548d3cdf4d768708708330c1b141/805c04b8c592400eb28358eb81f1a145.jpg, createdBy=4a299119890, createdName=Dehors, createdTime=Tue Jan 02 18:33:59 CST 2024, time=2024-01-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2199014, encodeId=3c17219901402, content=偏重的研究方向：心血管<br>经验分享：记录sr投稿进程 2024/4/17 投稿并技术审查, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74fe5476004, createdName=ms4000001914246765, createdTime=Wed Apr 17 20:21:27 CST 2024, time=15小时前, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2173392, encodeId=267721e339254, content=想问下大佬们，到这个阶段之后，后续会有editer has been invited 或者多少多少reviewers has been invited吗？还是就过几个礼拜直接到decision了？ We will now find the most suitable editor to manage the next steps of your submission. If your submission is successful, they will invite reviewers to peer review your work. This process can take a few weeks., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230712/7b1f2dc9a324479e9877047bc3d85ecd/b95cd487c3e24b4d8bfa2fc6ab30880c.jpg, createdBy=aed48754576, createdName=发大文章带我一个二十作吧, createdTime=Wed Dec 06 23:30:26 CST 2023, time=2023-12-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2191565, encodeId=be7b2191565a6, content=The editors' decision can take several weeks as they may consult peer reviewers.今天我的从初始状态变成这个了，但是之前我看到都邀请审稿人了，这等于是又重新来了一遍啊，大佬们看看是这样吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ac75721162, createdName=峪奇不奇, createdTime=Wed Mar 06 18:58:02 CST 2024, time=2024-03-06, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2189221, encodeId=a79f21892213a, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：有没有已经接收的朋友，进入支付版面费的链接之后又让点一个按钮说发了另一个链接到邮件里，这是什么邮件啊，通讯作者没有收到邮件，有知道的朋友吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/04/30/d54ac6a658ea322ab205e4e0c0ff4977.jpg, createdBy=88b35325254, createdName=尽在不言中, createdTime=Sun Feb 25 09:09:20 CST 2024, time=2024-02-25, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2150320, encodeId=3ba1215032042, content=偏重的研究方向：生物信息学;肿瘤<br>经验分享：大家一般邀请几个审稿人啊，我邀请了五个，都接受审稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c178590765, createdName=ms5000000683483699, createdTime=Fri Jul 28 23:15:56 CST 2023, time=2023-07-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2195926, encodeId=31e8219592616, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向：基础<br>经验分享：2023年6月4日投稿，2024年3月25日接收。9个多月，终于过关了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a26a1720733, createdName=萝布, createdTime=Thu Mar 28 19:54:17 CST 2024, time=2024-03-28, status=1, ipAttribution=湖北省)]
    15小时前 ms4000001914246765 来自湖北省

    偏重的研究方向：心血管
    经验分享：记录sr投稿进程 2024/4/17 投稿并技术审查

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2194666, encodeId=710421946668f, content=两个月还没找到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9fab6517805, createdName=ms7000000307422374, createdTime=Fri Mar 22 13:19:23 CST 2024, time=2024-03-22, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2198891, encodeId=7270219889143, content=请问一下大家在track snapp submission界面看是pass technical checks, 然后点view submission details看是under peer review，中间没有任何invite editor和invite reviewer的消息，请问这个是怎么回事呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa3d9260658, createdName=ms7000000714401863, createdTime=Wed Apr 17 04:05:25 CST 2024, time=昨天, status=1, ipAttribution=康涅狄格), GetPortalCommentsPageByObjectIdResponse(id=2199091, encodeId=18ae219909107, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0dd59219282, createdName=ms7000000828059346, createdTime=Thu Apr 18 10:52:12 CST 2024, time=1小时前, status=0, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2178836, encodeId=212721e883660, content=偏重的研究方向：生物信息学;肿瘤;Cancer<br>经验分享：- [ ] 2023.12.26 submission received - [ ] 2023.12.26 submission is under technical check - [ ] 2023.12.27 submission passed technical check - [ ] 2023.12.27 editor invited - [ ] 2023.12.27 editor assigned - [ ] 2023.12.27 reviewers invited(3) - [ ] 2023.12.27 1 reviewer(s) accepted - [ ] 2023.12.30 2 reviewer(s) accepted (Awaiting their report), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240102/21c3548d3cdf4d768708708330c1b141/805c04b8c592400eb28358eb81f1a145.jpg, createdBy=4a299119890, createdName=Dehors, createdTime=Tue Jan 02 18:33:59 CST 2024, time=2024-01-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2199014, encodeId=3c17219901402, content=偏重的研究方向：心血管<br>经验分享：记录sr投稿进程 2024/4/17 投稿并技术审查, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74fe5476004, createdName=ms4000001914246765, createdTime=Wed Apr 17 20:21:27 CST 2024, time=15小时前, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2173392, encodeId=267721e339254, content=想问下大佬们，到这个阶段之后，后续会有editer has been invited 或者多少多少reviewers has been invited吗？还是就过几个礼拜直接到decision了？ We will now find the most suitable editor to manage the next steps of your submission. If your submission is successful, they will invite reviewers to peer review your work. This process can take a few weeks., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230712/7b1f2dc9a324479e9877047bc3d85ecd/b95cd487c3e24b4d8bfa2fc6ab30880c.jpg, createdBy=aed48754576, createdName=发大文章带我一个二十作吧, createdTime=Wed Dec 06 23:30:26 CST 2023, time=2023-12-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2191565, encodeId=be7b2191565a6, content=The editors' decision can take several weeks as they may consult peer reviewers.今天我的从初始状态变成这个了，但是之前我看到都邀请审稿人了，这等于是又重新来了一遍啊，大佬们看看是这样吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ac75721162, createdName=峪奇不奇, createdTime=Wed Mar 06 18:58:02 CST 2024, time=2024-03-06, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2189221, encodeId=a79f21892213a, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：有没有已经接收的朋友，进入支付版面费的链接之后又让点一个按钮说发了另一个链接到邮件里，这是什么邮件啊，通讯作者没有收到邮件，有知道的朋友吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/04/30/d54ac6a658ea322ab205e4e0c0ff4977.jpg, createdBy=88b35325254, createdName=尽在不言中, createdTime=Sun Feb 25 09:09:20 CST 2024, time=2024-02-25, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2150320, encodeId=3ba1215032042, content=偏重的研究方向：生物信息学;肿瘤<br>经验分享：大家一般邀请几个审稿人啊，我邀请了五个，都接受审稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c178590765, createdName=ms5000000683483699, createdTime=Fri Jul 28 23:15:56 CST 2023, time=2023-07-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2195926, encodeId=31e8219592616, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向：基础<br>经验分享：2023年6月4日投稿，2024年3月25日接收。9个多月，终于过关了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a26a1720733, createdName=萝布, createdTime=Thu Mar 28 19:54:17 CST 2024, time=2024-03-28, status=1, ipAttribution=湖北省)]
    2023-12-06 发大文章带我一个二十作吧 来自上海

    想问下大佬们，到这个阶段之后，后续会有editer has been invited 或者多少多少reviewers has been invited吗？还是就过几个礼拜直接到decision了？ We will now find the most suitable editor to manage the next steps of your submission. If your submission is successful, they will invite reviewers to peer review your work. This process can take a few weeks.

    11

    展开11条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2194666, encodeId=710421946668f, content=两个月还没找到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9fab6517805, createdName=ms7000000307422374, createdTime=Fri Mar 22 13:19:23 CST 2024, time=2024-03-22, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2198891, encodeId=7270219889143, content=请问一下大家在track snapp submission界面看是pass technical checks, 然后点view submission details看是under peer review，中间没有任何invite editor和invite reviewer的消息，请问这个是怎么回事呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa3d9260658, createdName=ms7000000714401863, createdTime=Wed Apr 17 04:05:25 CST 2024, time=昨天, status=1, ipAttribution=康涅狄格), GetPortalCommentsPageByObjectIdResponse(id=2199091, encodeId=18ae219909107, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0dd59219282, createdName=ms7000000828059346, createdTime=Thu Apr 18 10:52:12 CST 2024, time=1小时前, status=0, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2178836, encodeId=212721e883660, content=偏重的研究方向：生物信息学;肿瘤;Cancer<br>经验分享：- [ ] 2023.12.26 submission received - [ ] 2023.12.26 submission is under technical check - [ ] 2023.12.27 submission passed technical check - [ ] 2023.12.27 editor invited - [ ] 2023.12.27 editor assigned - [ ] 2023.12.27 reviewers invited(3) - [ ] 2023.12.27 1 reviewer(s) accepted - [ ] 2023.12.30 2 reviewer(s) accepted (Awaiting their report), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240102/21c3548d3cdf4d768708708330c1b141/805c04b8c592400eb28358eb81f1a145.jpg, createdBy=4a299119890, createdName=Dehors, createdTime=Tue Jan 02 18:33:59 CST 2024, time=2024-01-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2199014, encodeId=3c17219901402, content=偏重的研究方向：心血管<br>经验分享：记录sr投稿进程 2024/4/17 投稿并技术审查, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74fe5476004, createdName=ms4000001914246765, createdTime=Wed Apr 17 20:21:27 CST 2024, time=15小时前, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2173392, encodeId=267721e339254, content=想问下大佬们，到这个阶段之后，后续会有editer has been invited 或者多少多少reviewers has been invited吗？还是就过几个礼拜直接到decision了？ We will now find the most suitable editor to manage the next steps of your submission. If your submission is successful, they will invite reviewers to peer review your work. This process can take a few weeks., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230712/7b1f2dc9a324479e9877047bc3d85ecd/b95cd487c3e24b4d8bfa2fc6ab30880c.jpg, createdBy=aed48754576, createdName=发大文章带我一个二十作吧, createdTime=Wed Dec 06 23:30:26 CST 2023, time=2023-12-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2191565, encodeId=be7b2191565a6, content=The editors' decision can take several weeks as they may consult peer reviewers.今天我的从初始状态变成这个了，但是之前我看到都邀请审稿人了，这等于是又重新来了一遍啊，大佬们看看是这样吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ac75721162, createdName=峪奇不奇, createdTime=Wed Mar 06 18:58:02 CST 2024, time=2024-03-06, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2189221, encodeId=a79f21892213a, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：有没有已经接收的朋友，进入支付版面费的链接之后又让点一个按钮说发了另一个链接到邮件里，这是什么邮件啊，通讯作者没有收到邮件，有知道的朋友吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/04/30/d54ac6a658ea322ab205e4e0c0ff4977.jpg, createdBy=88b35325254, createdName=尽在不言中, createdTime=Sun Feb 25 09:09:20 CST 2024, time=2024-02-25, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2150320, encodeId=3ba1215032042, content=偏重的研究方向：生物信息学;肿瘤<br>经验分享：大家一般邀请几个审稿人啊，我邀请了五个，都接受审稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c178590765, createdName=ms5000000683483699, createdTime=Fri Jul 28 23:15:56 CST 2023, time=2023-07-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2195926, encodeId=31e8219592616, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向：基础<br>经验分享：2023年6月4日投稿，2024年3月25日接收。9个多月，终于过关了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a26a1720733, createdName=萝布, createdTime=Thu Mar 28 19:54:17 CST 2024, time=2024-03-28, status=1, ipAttribution=湖北省)]
    2024-03-06 峪奇不奇 来自四川省

    The editors' decision can take several weeks as they may consult peer reviewers.今天我的从初始状态变成这个了，但是之前我看到都邀请审稿人了，这等于是又重新来了一遍啊，大佬们看看是这样吗？

    11

    展开11条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2194666, encodeId=710421946668f, content=两个月还没找到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9fab6517805, createdName=ms7000000307422374, createdTime=Fri Mar 22 13:19:23 CST 2024, time=2024-03-22, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2198891, encodeId=7270219889143, content=请问一下大家在track snapp submission界面看是pass technical checks, 然后点view submission details看是under peer review，中间没有任何invite editor和invite reviewer的消息，请问这个是怎么回事呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa3d9260658, createdName=ms7000000714401863, createdTime=Wed Apr 17 04:05:25 CST 2024, time=昨天, status=1, ipAttribution=康涅狄格), GetPortalCommentsPageByObjectIdResponse(id=2199091, encodeId=18ae219909107, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0dd59219282, createdName=ms7000000828059346, createdTime=Thu Apr 18 10:52:12 CST 2024, time=1小时前, status=0, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2178836, encodeId=212721e883660, content=偏重的研究方向：生物信息学;肿瘤;Cancer<br>经验分享：- [ ] 2023.12.26 submission received - [ ] 2023.12.26 submission is under technical check - [ ] 2023.12.27 submission passed technical check - [ ] 2023.12.27 editor invited - [ ] 2023.12.27 editor assigned - [ ] 2023.12.27 reviewers invited(3) - [ ] 2023.12.27 1 reviewer(s) accepted - [ ] 2023.12.30 2 reviewer(s) accepted (Awaiting their report), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240102/21c3548d3cdf4d768708708330c1b141/805c04b8c592400eb28358eb81f1a145.jpg, createdBy=4a299119890, createdName=Dehors, createdTime=Tue Jan 02 18:33:59 CST 2024, time=2024-01-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2199014, encodeId=3c17219901402, content=偏重的研究方向：心血管<br>经验分享：记录sr投稿进程 2024/4/17 投稿并技术审查, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74fe5476004, createdName=ms4000001914246765, createdTime=Wed Apr 17 20:21:27 CST 2024, time=15小时前, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2173392, encodeId=267721e339254, content=想问下大佬们，到这个阶段之后，后续会有editer has been invited 或者多少多少reviewers has been invited吗？还是就过几个礼拜直接到decision了？ We will now find the most suitable editor to manage the next steps of your submission. If your submission is successful, they will invite reviewers to peer review your work. This process can take a few weeks., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230712/7b1f2dc9a324479e9877047bc3d85ecd/b95cd487c3e24b4d8bfa2fc6ab30880c.jpg, createdBy=aed48754576, createdName=发大文章带我一个二十作吧, createdTime=Wed Dec 06 23:30:26 CST 2023, time=2023-12-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2191565, encodeId=be7b2191565a6, content=The editors' decision can take several weeks as they may consult peer reviewers.今天我的从初始状态变成这个了，但是之前我看到都邀请审稿人了，这等于是又重新来了一遍啊，大佬们看看是这样吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ac75721162, createdName=峪奇不奇, createdTime=Wed Mar 06 18:58:02 CST 2024, time=2024-03-06, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2189221, encodeId=a79f21892213a, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：有没有已经接收的朋友，进入支付版面费的链接之后又让点一个按钮说发了另一个链接到邮件里，这是什么邮件啊，通讯作者没有收到邮件，有知道的朋友吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/04/30/d54ac6a658ea322ab205e4e0c0ff4977.jpg, createdBy=88b35325254, createdName=尽在不言中, createdTime=Sun Feb 25 09:09:20 CST 2024, time=2024-02-25, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2150320, encodeId=3ba1215032042, content=偏重的研究方向：生物信息学;肿瘤<br>经验分享：大家一般邀请几个审稿人啊，我邀请了五个，都接受审稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c178590765, createdName=ms5000000683483699, createdTime=Fri Jul 28 23:15:56 CST 2023, time=2023-07-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2195926, encodeId=31e8219592616, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向：基础<br>经验分享：2023年6月4日投稿，2024年3月25日接收。9个多月，终于过关了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a26a1720733, createdName=萝布, createdTime=Thu Mar 28 19:54:17 CST 2024, time=2024-03-28, status=1, ipAttribution=湖北省)]
    2024-02-25 尽在不言中 来自吉林省

    审稿速度:3.0 | 投稿命中率:50.0
    经验分享：有没有已经接收的朋友，进入支付版面费的链接之后又让点一个按钮说发了另一个链接到邮件里，这是什么邮件啊，通讯作者没有收到邮件，有知道的朋友吗

    4

    展开4条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2194666, encodeId=710421946668f, content=两个月还没找到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9fab6517805, createdName=ms7000000307422374, createdTime=Fri Mar 22 13:19:23 CST 2024, time=2024-03-22, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2198891, encodeId=7270219889143, content=请问一下大家在track snapp submission界面看是pass technical checks, 然后点view submission details看是under peer review，中间没有任何invite editor和invite reviewer的消息，请问这个是怎么回事呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa3d9260658, createdName=ms7000000714401863, createdTime=Wed Apr 17 04:05:25 CST 2024, time=昨天, status=1, ipAttribution=康涅狄格), GetPortalCommentsPageByObjectIdResponse(id=2199091, encodeId=18ae219909107, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0dd59219282, createdName=ms7000000828059346, createdTime=Thu Apr 18 10:52:12 CST 2024, time=1小时前, status=0, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2178836, encodeId=212721e883660, content=偏重的研究方向：生物信息学;肿瘤;Cancer<br>经验分享：- [ ] 2023.12.26 submission received - [ ] 2023.12.26 submission is under technical check - [ ] 2023.12.27 submission passed technical check - [ ] 2023.12.27 editor invited - [ ] 2023.12.27 editor assigned - [ ] 2023.12.27 reviewers invited(3) - [ ] 2023.12.27 1 reviewer(s) accepted - [ ] 2023.12.30 2 reviewer(s) accepted (Awaiting their report), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240102/21c3548d3cdf4d768708708330c1b141/805c04b8c592400eb28358eb81f1a145.jpg, createdBy=4a299119890, createdName=Dehors, createdTime=Tue Jan 02 18:33:59 CST 2024, time=2024-01-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2199014, encodeId=3c17219901402, content=偏重的研究方向：心血管<br>经验分享：记录sr投稿进程 2024/4/17 投稿并技术审查, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74fe5476004, createdName=ms4000001914246765, createdTime=Wed Apr 17 20:21:27 CST 2024, time=15小时前, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2173392, encodeId=267721e339254, content=想问下大佬们，到这个阶段之后，后续会有editer has been invited 或者多少多少reviewers has been invited吗？还是就过几个礼拜直接到decision了？ We will now find the most suitable editor to manage the next steps of your submission. If your submission is successful, they will invite reviewers to peer review your work. This process can take a few weeks., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230712/7b1f2dc9a324479e9877047bc3d85ecd/b95cd487c3e24b4d8bfa2fc6ab30880c.jpg, createdBy=aed48754576, createdName=发大文章带我一个二十作吧, createdTime=Wed Dec 06 23:30:26 CST 2023, time=2023-12-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2191565, encodeId=be7b2191565a6, content=The editors' decision can take several weeks as they may consult peer reviewers.今天我的从初始状态变成这个了，但是之前我看到都邀请审稿人了，这等于是又重新来了一遍啊，大佬们看看是这样吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ac75721162, createdName=峪奇不奇, createdTime=Wed Mar 06 18:58:02 CST 2024, time=2024-03-06, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2189221, encodeId=a79f21892213a, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：有没有已经接收的朋友，进入支付版面费的链接之后又让点一个按钮说发了另一个链接到邮件里，这是什么邮件啊，通讯作者没有收到邮件，有知道的朋友吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/04/30/d54ac6a658ea322ab205e4e0c0ff4977.jpg, createdBy=88b35325254, createdName=尽在不言中, createdTime=Sun Feb 25 09:09:20 CST 2024, time=2024-02-25, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2150320, encodeId=3ba1215032042, content=偏重的研究方向：生物信息学;肿瘤<br>经验分享：大家一般邀请几个审稿人啊，我邀请了五个，都接受审稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c178590765, createdName=ms5000000683483699, createdTime=Fri Jul 28 23:15:56 CST 2023, time=2023-07-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2195926, encodeId=31e8219592616, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向：基础<br>经验分享：2023年6月4日投稿，2024年3月25日接收。9个多月，终于过关了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a26a1720733, createdName=萝布, createdTime=Thu Mar 28 19:54:17 CST 2024, time=2024-03-28, status=1, ipAttribution=湖北省)]
    2023-07-28 ms5000000683483699 来自山东省

    偏重的研究方向：生物信息学;肿瘤
    经验分享：大家一般邀请几个审稿人啊，我邀请了五个，都接受审稿了

    6

    展开6条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2194666, encodeId=710421946668f, content=两个月还没找到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9fab6517805, createdName=ms7000000307422374, createdTime=Fri Mar 22 13:19:23 CST 2024, time=2024-03-22, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2198891, encodeId=7270219889143, content=请问一下大家在track snapp submission界面看是pass technical checks, 然后点view submission details看是under peer review，中间没有任何invite editor和invite reviewer的消息，请问这个是怎么回事呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa3d9260658, createdName=ms7000000714401863, createdTime=Wed Apr 17 04:05:25 CST 2024, time=昨天, status=1, ipAttribution=康涅狄格), GetPortalCommentsPageByObjectIdResponse(id=2199091, encodeId=18ae219909107, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0dd59219282, createdName=ms7000000828059346, createdTime=Thu Apr 18 10:52:12 CST 2024, time=1小时前, status=0, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2178836, encodeId=212721e883660, content=偏重的研究方向：生物信息学;肿瘤;Cancer<br>经验分享：- [ ] 2023.12.26 submission received - [ ] 2023.12.26 submission is under technical check - [ ] 2023.12.27 submission passed technical check - [ ] 2023.12.27 editor invited - [ ] 2023.12.27 editor assigned - [ ] 2023.12.27 reviewers invited(3) - [ ] 2023.12.27 1 reviewer(s) accepted - [ ] 2023.12.30 2 reviewer(s) accepted (Awaiting their report), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240102/21c3548d3cdf4d768708708330c1b141/805c04b8c592400eb28358eb81f1a145.jpg, createdBy=4a299119890, createdName=Dehors, createdTime=Tue Jan 02 18:33:59 CST 2024, time=2024-01-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2199014, encodeId=3c17219901402, content=偏重的研究方向：心血管<br>经验分享：记录sr投稿进程 2024/4/17 投稿并技术审查, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74fe5476004, createdName=ms4000001914246765, createdTime=Wed Apr 17 20:21:27 CST 2024, time=15小时前, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2173392, encodeId=267721e339254, content=想问下大佬们，到这个阶段之后，后续会有editer has been invited 或者多少多少reviewers has been invited吗？还是就过几个礼拜直接到decision了？ We will now find the most suitable editor to manage the next steps of your submission. If your submission is successful, they will invite reviewers to peer review your work. This process can take a few weeks., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230712/7b1f2dc9a324479e9877047bc3d85ecd/b95cd487c3e24b4d8bfa2fc6ab30880c.jpg, createdBy=aed48754576, createdName=发大文章带我一个二十作吧, createdTime=Wed Dec 06 23:30:26 CST 2023, time=2023-12-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2191565, encodeId=be7b2191565a6, content=The editors' decision can take several weeks as they may consult peer reviewers.今天我的从初始状态变成这个了，但是之前我看到都邀请审稿人了，这等于是又重新来了一遍啊，大佬们看看是这样吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ac75721162, createdName=峪奇不奇, createdTime=Wed Mar 06 18:58:02 CST 2024, time=2024-03-06, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2189221, encodeId=a79f21892213a, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：有没有已经接收的朋友，进入支付版面费的链接之后又让点一个按钮说发了另一个链接到邮件里，这是什么邮件啊，通讯作者没有收到邮件，有知道的朋友吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/04/30/d54ac6a658ea322ab205e4e0c0ff4977.jpg, createdBy=88b35325254, createdName=尽在不言中, createdTime=Sun Feb 25 09:09:20 CST 2024, time=2024-02-25, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2150320, encodeId=3ba1215032042, content=偏重的研究方向：生物信息学;肿瘤<br>经验分享：大家一般邀请几个审稿人啊，我邀请了五个，都接受审稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c178590765, createdName=ms5000000683483699, createdTime=Fri Jul 28 23:15:56 CST 2023, time=2023-07-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2195926, encodeId=31e8219592616, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向：基础<br>经验分享：2023年6月4日投稿，2024年3月25日接收。9个多月，终于过关了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a26a1720733, createdName=萝布, createdTime=Thu Mar 28 19:54:17 CST 2024, time=2024-03-28, status=1, ipAttribution=湖北省)]
    2024-03-28 萝布 来自湖北省

    审稿速度:3.0 | 投稿命中率:25.0
    偏重的研究方向：基础
    经验分享：2023年6月4日投稿，2024年3月25日接收。9个多月，终于过关了。

    1

    展开1条回复
共500条页码: 1/50页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分